Short-term outcomes after primary total mesorectal excision (TME) versus local excision followed by completion TME for early rectal cancer: population-based propensity-matched study
- PMID: 39235090
- PMCID: PMC11375580
- DOI: 10.1093/bjsopen/zrae103
Short-term outcomes after primary total mesorectal excision (TME) versus local excision followed by completion TME for early rectal cancer: population-based propensity-matched study
Abstract
Background: Colorectal cancer screening programmes have led to a shift towards early-stage colorectal cancer, which, in selected cases, can be treated using local excision. However, local excision followed by completion total mesorectal excision (two-stage approach) may be associated with less favourable outcomes than primary total mesorectal excision (one-stage approach). The aim of this population study was to determine the distribution of treatment strategies for early rectal cancer in the Netherlands and to compare the short-term outcomes of primary total mesorectal excision with those of local excision followed by completion total mesorectal excision.
Methods: Short-term data for patients with cT1-2 N0xM0 rectal cancer who underwent local excision only, primary total mesorectal excision, or local excision followed by completion total mesorectal excision between 2012 and 2020 in the Netherlands were collected from the Dutch Colorectal Audit. Patients were categorized according to treatment groups and logistic regressions were performed after multiple imputation and propensity score matching. The primary outcome was the end-ostomy rate.
Results: From 2015 to 2020, the proportion for the two-stage approach increased from 22.3% to 43.9%. After matching, 1062 patients were included. The end-ostomy rate was 16.8% for the primary total mesorectal excision group versus 29.6% for the local excision followed by completion total mesorectal excision group (P < 0.001). The primary total mesorectal excision group had a higher re-intervention rate than the local excision followed by completion total mesorectal excision group (16.7% versus 11.8%; P = 0.048). No differences were observed with regard to complications, conversion, diverting ostomies, radical resections, readmissions, and death.
Conclusion: This study shows that, over time, cT1-2 rectal cancer has increasingly been treated using the two-stage approach. However, local excision followed by completion total mesorectal excision seems to be associated with an elevated end-ostomy rate. It is important that clinicians and patients are aware of this risk during shared decision-making.
© The Author(s) 2024. Published by Oxford University Press on behalf of BJS Foundation Ltd.
Figures





Similar articles
-
Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.Dis Colon Rectum. 2020 Nov;63(11):1500-1510. doi: 10.1097/DCR.0000000000001725. Dis Colon Rectum. 2020. PMID: 33044291
-
Short-term outcomes of transanal completion total mesorectal excision (cTaTME) for rectal cancer: a case-matched analysis.Surg Endosc. 2019 Jan;33(1):103-109. doi: 10.1007/s00464-018-6280-3. Epub 2018 Jul 2. Surg Endosc. 2019. PMID: 29967991 Free PMC article.
-
Completion total mesorectal excision following transanal endoscopic microsurgery does not compromise outcomes in patients with rectal cancer.Surg Endosc. 2022 Feb;36(2):1181-1190. doi: 10.1007/s00464-021-08385-2. Epub 2021 Feb 24. Surg Endosc. 2022. PMID: 33629183
-
Does previous transanal excision for early rectal cancer impair surgical outcomes and pathologic findings of completion total mesorectal excision? Results of a systematic review of the literature.J Visc Surg. 2018 Dec;155(6):445-452. doi: 10.1016/j.jviscsurg.2018.03.008. Epub 2018 Apr 12. J Visc Surg. 2018. PMID: 29657063
-
Completion Total Mesorectal Excision After Transanal Local Excision of Early Rectal Cancer: A Systematic Review and Meta-analysis.Dis Colon Rectum. 2022 May 1;65(5):628-640. doi: 10.1097/DCR.0000000000002407. Dis Colon Rectum. 2022. PMID: 35143429
Cited by
-
Mid- and long-term functional outcomes of advancement flap for cryptoglandular perianal fistulas.Tech Coloproctol. 2025 May 9;29(1):112. doi: 10.1007/s10151-025-03148-w. Tech Coloproctol. 2025. PMID: 40346397 Free PMC article.
-
Stoma Rate and Oncological Outcomes of Primary TaTME vs Completion TaTME in Patients With Early-Stage Rectal Cancer.Dis Colon Rectum. 2025 Aug 1;68(8):962-971. doi: 10.1097/DCR.0000000000003794. Epub 2025 May 5. Dis Colon Rectum. 2025. PMID: 40323649 Free PMC article.
References
-
- Integraal Kankercentrum Nederland (IKNL) . Cijfers Darmkanker. 2022. https://iknl.nl/kankersoorten/darmkanker/registratie (accessed 19 January 2023)
-
- Lezoche E, Paganini AM, Fabiani B, Balla A, Vestri A, Pescatori L et al. Quality-of-life impairment after endoluminal locoregional resection and laparoscopic total mesorectal excision. Surg Endosc 2014;28:227–234 - PubMed
-
- Traa MJ, Orsini RG, Den Oudsten BL, De Vries J, Roukema JA, Bosman SJ et al. Measuring the health-related quality of life and sexual functioning of patients with rectal cancer: does type of treatment matter? Int J Cancer 2014;134:979–987 - PubMed
-
- Borstlap WAA, van Oostendorp SE, Klaver CEL, Hahnloser D, Cunningham C, Rullier E et al. Organ preservation in rectal cancer: a synopsis of current guidelines. Colorectal Dis 2018;20:201–210 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources